Back to Search Start Over

An unusual neurological presentation in a patient with primary hypereosinophilic syndrome.

Authors :
Spina E
Maniscalco GT
Petraroli A
Detoraki A
Servillo G
Ranieri A
De Mase A
Renna R
Candelaresi P
De Paulis A
Andreone V
Source :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2022 Nov; Vol. 31 (11), pp. 106703. Date of Electronic Publication: 2022 Sep 05.
Publication Year :
2022

Abstract

Hypereosinophilic syndromes are characterized by an increased number of blood eosinophils (usually more than 1.5 × 10 <superscript>9</superscript> ) infiltrating tissues and causing organ damage through over-production of pro-inflammatory cytokines with heterogeneous clinical presentation. Here we present a case of a 47 years old male, with an unremarkable previous medical history, with a sudden onset of subungual hemorrhage and low back pain. Admitted for right arm weakness and vomiting, was raised the suspicion of acute cerebrovascular syndrome, but a brain CT scan with angiogram and perfusion sequences did not show any signs of early ischaemic lesions; conversely, lab tests revealed an increased peripheral eosinophil blood count. Clinical conditions rapidly worsened and a brain MRI showed multiple sub-acute ischaemic lesions compatible with vasculitis while EEG was in favor of widespread cortical distress. Diagnosis of the hypereosinophilic syndrome was made through peripheral blood smear and osteo-medullar biopsy, which showed a rich prevalence of eosinophils. The molecular biology testing showed FIP1L1-PDGRA gene mutation. Despite the prompt therapy beginning with intravenous corticosteroids and tyrosine-kinase inhibitors with normalization of cell blood count in a few days, the patient remained in minimal consciousness. When facing unusual symptoms onset (low back pain with weakness in one limb) and a highly impaired WBC not consistent with other courses (such as infections, vasculitis, allergies, and other diseases involving the immune system) clinicians should take into account the possibility of a hematological disorder and treat it as soon as possible to avoid a poor prognosis.<br />Competing Interests: Declaration of Competing Interest The authors declare no conflicts of interests.<br /> (Copyright © 2022 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1532-8511
Volume :
31
Issue :
11
Database :
MEDLINE
Journal :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Publication Type :
Report
Accession number :
36075130
Full Text :
https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106703